Current Focus: Evobiotics

Evobiotics was founded In 2016 with the purpose of discovering novel antimicrobial compounds to treat bacterial & fungal infections in humans.  It is currently supported by seed funding from Acidophil, and is seeking grants in 2019 to fund its research and development efforts.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.